The global COVID-19 sample collection kits market size reached USD 7.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.6 Billion by 2033, exhibiting a growth rate (CAGR) of 2.94% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Time Period | 2024-2033 |
Market Size in 2024
|
USD 7.2 Billion |
Market Forecast in 2033
|
USD 9.6 Billion |
Market Growth Rate 2025-2033 | 2.94% |
COVID-19 sample collection kits refer to in-vitro diagnostic medical equipment utilized for collecting biological specimens for detecting the SARS-CoV-2 virus. It is a vital step in the effective diagnosis of an active infection of the novel coronavirus in the body. Various health organizations, such as the Centers for Disease Control and Prevention (CDC) and the United States Food and Drug Administration (USFDA), have introduced standard procedures and guidelines for manufacturers to develop COVID-19 sample collection and transport kits that are compatible with the recommended configurations. With the rising number of hospitals expanding their testing capabilities, the demand for COVID-19 collection sample kits is escalating across the globe.
The global COVID-19 sample collection kits market is primarily driven by the growing geriatric population and the increasing number of people suffering from chronic diseases who are more prone to COVID-19 infections. Besides this, governments of several countries are undertaking various initiatives to provide sample collection kits to the masses at an affordable price. The extensive research and development (R&D) activities by the manufacturers in collaboration with the regional authorities and suppliers are also propelling the market growth. For instance, the introduction of a 3D printed nasal swab prototype for commercial use by researchers at the University of South Florida Health has positively impacted the market growth. Furthermore, the availability of swabs in various configurations for the advanced detection of infections has also led to increased adoption of COVID-19 sample collection kits across multiple healthcare centers and hospitals.
IMARC Group provides an analysis of the key trends in each sub-segment of the global COVID-19 sample collection kits market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on product, application and site of collection.
Breakup by Product:
Breakup by Application:
Breakup by Site of Collection:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Becton Dickinson and Company, COPAN Diagnostics, Formlabs, Hardy Diagnostics, HiMedia Laboratories, Laboratory Corporation of America Holdings, Lucence Health Inc., Medline Industries Inc., Puritan Medical Products, Thermo Fisher Scientific Inc. and VIRCELL S.L.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Time Period | 2024-2033 |
Units | Billion USD |
Products Covered |
|
Applications Covered | Diagnostics, Research |
Site of Collections Covered | Hospitals and Clinics, Home Test |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Becton Dickinson and Company, COPAN Diagnostics, Formlabs, Hardy Diagnostics, HiMedia Laboratories, Laboratory Corporation of America Holdings, Lucence Health Inc., Medline Industries Inc., Puritan Medical Products, Thermo Fisher Scientific Inc. and VIRCELL S.L. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The covid-19 sample collection kits market was valued at USD 7.2 Billion in 2024.
The covid-19 sample collection kits market is projected to exhibit a CAGR of 2.94% during 2025-2033.
The COVID-19 sample collection kits market is driven by the global demand for widespread testing to control virus transmission, advancements in diagnostic technologies, and increased government funding for public health initiatives.
Europe currently dominates the market, driven by the region's strong healthcare infrastructure, increased demand for testing, government initiatives, and the rising need for rapid, accurate diagnostic solutions during the pandemic.
Some of the major players in the covid-19 sample collection kits market include Becton Dickinson and Company, COPAN Diagnostics, Formlabs, Hardy Diagnostics, HiMedia Laboratories, Laboratory Corporation of America Holdings, Lucence Health Inc., Medline Industries Inc., Puritan Medical Products, Thermo Fisher Scientific Inc. and VIRCELL S.L.